Literature DB >> 26998050

SNPs in the aryl hydrocarbon receptor-interacting protein gene associated with sporadic non-functioning pituitary adenoma.

Yeshuai Hu1, Jun Yang1, Yongkai Chang1, Shunchang Ma1, Jianfa Qi1.   

Abstract

Mutations in the aryl hydrocarbon receptor-interacting protein (AIP) gene have previously been associated with a predisposition to pituitary adenomas. However, to the best of our knowledge, mutations in AIP that relate specifically to sporadic non-functioning pituitary adenomas (NFPAs) have yet to be reported. Therefore, the present study aimed to identify single nucleotide polymorphisms (SNPs) in the AIP gene that may be associated with NFPAs. Peripheral blood samples and the entire coding sequence of the AIP gene from 56 patients with NFPAs and 56 controls were analyzed in triplicate. Of the 56 patients with NFPAs, 9 patients (16.1%) were identified as harboring five different SNPs, although no germline mutations in the AIP gene were detected in any of the patients. Three different SNPs (7051C>T, 8012G>C and 8020G>C) were identified in exons 4 and 6 in 3 different patients (each in 1 patient). Two different SNPs (7318C>A and 7886A>G) were identified in exons 5 and 6, respectively, in 6 different patients (each in 3 patients). No SNPs or germline mutations in the AIP gene were identified in the controls. The results of the present study suggested that mutations in the AIP gene might not have an important role in the tumorigenesis of NFPAs. However, further studies are required in order to investigate potential molecular and genetic mechanisms that may underlie the involvement of AIP in NFPA.

Entities:  

Keywords:  aryl hydrocarbon receptor-interacting protein; non-functioning pituitary adenoma; single nucleotide polymorphism

Year:  2016        PMID: 26998050      PMCID: PMC4774588          DOI: 10.3892/etm.2016.3002

Source DB:  PubMed          Journal:  Exp Ther Med        ISSN: 1792-0981            Impact factor:   2.447


  27 in total

Review 1.  The PAS superfamily: sensors of environmental and developmental signals.

Authors:  Y Z Gu; J B Hogenesch; C A Bradfield
Journal:  Annu Rev Pharmacol Toxicol       Date:  2000       Impact factor: 13.820

Review 2.  Molecular targets in pituitary tumours.

Authors:  Anthony P Heaney; Shlomo Melmed
Journal:  Nat Rev Cancer       Date:  2004-04       Impact factor: 60.716

3.  Clinical characterization of familial isolated pituitary adenomas.

Authors:  A F Daly; M-L Jaffrain-Rea; A Ciccarelli; H Valdes-Socin; V Rohmer; G Tamburrano; C Borson-Chazot; B Estour; E Ciccarelli; T Brue; P Ferolla; P Emy; A Colao; E De Menis; P Lecomte; F Penfornis; B Delemer; J Bertherat; J L Wémeau; W De Herder; F Archambeaud; A Stevenaert; A Calender; A Murat; F Cavagnini; A Beckers
Journal:  J Clin Endocrinol Metab       Date:  2006-06-20       Impact factor: 5.958

4.  Germline AIP mutations in apparently sporadic pituitary adenomas: prevalence in a prospective single-center cohort of 443 patients.

Authors:  Laure Cazabat; Jérôme Bouligand; Sylvie Salenave; Michèle Bernier; Stephan Gaillard; Fabrice Parker; Jacques Young; Anne Guiochon-Mantel; Philippe Chanson
Journal:  J Clin Endocrinol Metab       Date:  2012-02-08       Impact factor: 5.958

5.  High-mobility group A2 gene expression is frequently induced in non-functioning pituitary adenomas (NFPAs), even in the absence of chromosome 12 polysomy.

Authors:  Giovanna Maria Pierantoni; Palma Finelli; Emanuele Valtorta; Daniela Giardino; Ornella Rodeschini; Francesco Esposito; Marco Losa; Alfredo Fusco; Lidia Larizza
Journal:  Endocr Relat Cancer       Date:  2005-12       Impact factor: 5.678

6.  High prevalence of AIP gene mutations following focused screening in young patients with sporadic pituitary macroadenomas.

Authors:  Maria A Tichomirowa; Anne Barlier; Adrian F Daly; Marie-Lise Jaffrain-Rea; Cristina Ronchi; Maria Yaneva; Jonathan D Urban; Patrick Petrossians; Atanaska Elenkova; Antoine Tabarin; Rachel Desailloud; Dominique Maiter; Thomas Schürmeyer; Renato Cozzi; Marily Theodoropoulou; Caroline Sievers; Ignacio Bernabeu; Luciana A Naves; Olivier Chabre; Carmen Fajardo Montañana; Vaclav Hana; Georges Halaby; Brigitte Delemer; José Ignacio Labarta Aizpún; Emmanuel Sonnet; Angel Ferrandez Longás; Marie-Thérèse Hagelstein; Philippe Caron; Günter K Stalla; Vincent Bours; Sabina Zacharieva; Anna Spada; Thierry Brue; Albert Beckers
Journal:  Eur J Endocrinol       Date:  2011-07-13       Impact factor: 6.664

7.  AIP mutation in pituitary adenomas in the 18th century and today.

Authors:  Harvinder S Chahal; Karen Stals; Martina Unterländer; David J Balding; Mark G Thomas; Ajith V Kumar; G Michael Besser; A Brew Atkinson; Patrick J Morrison; Trevor A Howlett; Miles J Levy; Steve M Orme; Scott A Akker; Richard L Abel; Ashley B Grossman; Joachim Burger; Sian Ellard; Márta Korbonits
Journal:  N Engl J Med       Date:  2011-01-06       Impact factor: 91.245

Review 8.  The pathophysiology of pituitary adenomas.

Authors:  Dorota Dworakowska; Ashley B Grossman
Journal:  Best Pract Res Clin Endocrinol Metab       Date:  2009-10       Impact factor: 4.690

9.  AIP Mutations are not identified in patients with sporadic pituitary adenomas.

Authors:  Rebecca DiGiovanni; Stefano Serra; Shereen Ezzat; Sylvia L Asa
Journal:  Endocr Pathol       Date:  2007       Impact factor: 3.943

10.  Germline mutation in the aryl hydrocarbon receptor interacting protein gene in familial somatotropinoma.

Authors:  Rodrigo A Toledo; Delmar M Lourenço; Bernardo Liberman; Malebranche B C Cunha-Neto; Maria G Cavalcanti; Cinthia B Moyses; Sergio P A Toledo; Patricia L M Dahia
Journal:  J Clin Endocrinol Metab       Date:  2007-03-06       Impact factor: 5.958

View more
  2 in total

Review 1.  Pathogenesis of non-functioning pituitary adenomas.

Authors:  Maria Chiara Zatelli
Journal:  Pituitary       Date:  2018-04       Impact factor: 4.107

Review 2.  The Role of Single-Nucleotide Polymorphisms in Pituitary Adenomas Tumorigenesis.

Authors:  Sumedh S Shah; Manish K Aghi
Journal:  Cancers (Basel)       Date:  2019-12-09       Impact factor: 6.639

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.